Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecan
Article in npj Breast Cancer (August 2023)
The most recent citing publications are shown below. View all 46 publications that cite this research output on Dimensions.
Potential target identification for osteosarcoma treatment: Gene expression re-analysis and drug repurposing
Article in Gene (December 2022)
Induced resistance to ifosfamide in osteosarcoma cells suggests a more aggressive tumor profile
Article in Biochemistry and Biophysics Reports (October 2022)